- Home
- ASG vs CYRX Comparison
ASG vs CYRX Comparison
Compare ASG & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASG
- CYRX
- Stock Information
- Founded
- ASG 1986
- CYRX 1999
- Country
- ASG United States
- CYRX United States
- Employees
- ASG N/A
- CYRX N/A
- Industry
- ASG Investment Managers
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- ASG Finance
- CYRX Health Care
- Exchange
- ASG Nasdaq
- CYRX Nasdaq
- Market Cap
- ASG 295.0M
- CYRX 277.5M
- IPO Year
- ASG N/A
- CYRX N/A
- Fundamental
- Price
- ASG $5.04
- CYRX $7.07
- Analyst Decision
- ASG
- CYRX Strong Buy
- Analyst Count
- ASG 0
- CYRX 8
- Target Price
- ASG N/A
- CYRX $10.75
- AVG Volume (30 Days)
- ASG 324.3K
- CYRX 432.2K
- Earning Date
- ASG 01-01-0001
- CYRX 05-07-2025
- Dividend Yield
- ASG 8.09%
- CYRX N/A
- EPS Growth
- ASG N/A
- CYRX N/A
- EPS
- ASG N/A
- CYRX N/A
- Revenue
- ASG N/A
- CYRX $232,134,000.00
- Revenue This Year
- ASG N/A
- CYRX N/A
- Revenue Next Year
- ASG N/A
- CYRX $8.19
- P/E Ratio
- ASG N/A
- CYRX N/A
- Revenue Growth
- ASG N/A
- CYRX 3.16
- 52 Week Low
- ASG $4.47
- CYRX $4.58
- 52 Week High
- ASG $5.71
- CYRX $16.89
- Technical
- Relative Strength Index (RSI)
- ASG 57.26
- CYRX 67.38
- Support Level
- ASG $4.93
- CYRX $5.43
- Resistance Level
- ASG $5.13
- CYRX $6.00
- Average True Range (ATR)
- ASG 0.11
- CYRX 0.47
- MACD
- ASG 0.04
- CYRX 0.16
- Stochastic Oscillator
- ASG 86.81
- CYRX 91.53
About ASG Liberty All-Star Growth Fund Inc.
Liberty All Star Growth Fund Inc is the United States based diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment in a diversified portfolio of equity securities. The company portfolio of investments consists of different industries such as consumer discretionary, consumer staples, healthcare, industrial, information technology and others.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.